Evidence map›Paper›PMID 42522937›Full record

ArticleSubstance use & addiction journal2026

The Behavioral Health Treatment Engagement and Retention Learning Collaborative to Improve Receipt and Continuity of Medication Treatment for Opioid Use Disorder.

Dushka Crane, Lareina La Flair, Shadia Jallaq, Adam Bartley, Marguerite Burns, Christine McClure, Andrew J Barnes, Julie M Donohue, Adam J Gordon

Abstract read
In one paragraph

Article in Substance use & addiction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dushka CraneOhio Colleges of Medicine, Government Resource Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0000-0003-4366-3878
Lareina La FlairOhio Colleges of Medicine, Government Resource Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0009-0001-4084-1694
Shadia JallaqOhio Colleges of Medicine, Government Resource Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0009-0003-8480-171X
Adam BartleyOhio Colleges of Medicine, Government Resource Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Marguerite BurnsDepartment of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.ORCID 0000-0002-0625-2861
Christine McClureDepartment of Health Policy and Management, University of Pittsburgh School of Public Health, PA, USA.
Andrew J BarnesDepartment of Health Policy, Virginia Commonwealth University, Richmond, VA, USA.ORCID 0000-0002-0357-3934
Julie M DonohueDepartment of Health Policy and Management, University of Pittsburgh School of Public Health, PA, USA.
Adam J GordonProgram for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0000-0002-2453-8871

Funding

Greater Intermountain Node (CTN-0151)UG1DA049444 · NIDA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Gerald T. Cochran, Gerald T. Cochran · 2019 to 2026
$16.8M
Improving quality measurement for opioid use disorder treatment using a multi-state Medicaid research networkRM1DA059365 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Andrew James Barnes, Julie Marie Donohue · 2023 to 2026
$9.3M
NIDA NIH HHS RM1 DA059365NIDA NIH HHS UG1 DA049444
6 · The paper itself

Abstract

Medicaid is the largest insurer for patients with opioid use disorder (OUD) and finances a disproportionate share of medication treatment for OUD (MOUD). Within Medicaid, initiation and continuity of MOUD are associated with improved outcomes, but substantial inequities across populations and care settings remain. The Medicaid Outcomes Distributed Research Network (MODRN) has supported Medicaid agency efforts to improve MOUD receipt and continuity of care. In the context of MODRN-Examining Quality Improvement for Medicaid Programs, the Behavioral Health Treatment Engagement and Retention Learning Collaborative (BHTER) will implement and evaluate interventions focused on improving quality and reducing variation in process and clinical outcomes in Medicaid patients with OUD. BHTER's aims are to (1) estimate the effects of a quality improvement intervention on receipt and continuity of MOUD in intervention practices relative to comparison practices, (2) examine whether a quality improvement intervention narrows racial gaps in rates and continuity of MOUD in intervention relative to comparison practices, (3) examine provider perspectives on the quality improvement intervention, with a focus on practice and process changes that resulted in improvement, and factors that impede or facilitate delivery of high-quality MOUD care. In this protocol paper, we describe the rationale, methods, and impact of BHTER.

Indexed as

Continuity of Patient CareOpiate Substitution TreatmentOpioid-Related DisordersQuality ImprovementAdherence InterventionsBuprenorphineHumansMedicaidUnited StatesBuprenorphinebuprenorphinecommunity mental health serviceslearning collaborativeMedicaidopioid-related disorders

Identifiers

PMID42522937
PMCPMC13540076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.